Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intuniv Tablets post-marketing pediatric use-results survey in ADHD
jRCT1080223870Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of guanfacine in attention deficit hyperactivity disorder (ADHD), sponsored by Shionogi & Co., Ltd. Started Apr 2018; status: completed.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on jRCT1080223870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223870.